Evidence map›Paper›PMID 30971238›Full record

ArticleMicrobial cell factories2019

Enhanced production of antifungal lipopeptide iturin A by Bacillus amyloliquefaciens LL3 through metabolic engineering and culture conditions optimization.

Yulei Dang, Fengjie Zhao, Xiangsheng Liu, Xu Fan, Rui Huang, Weixia Gao, Shufang Wang, Chao Yang

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
17.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 126 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Antimicrobial Activity ofInternational journal of molecular sciences · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Lipopeptides from Bacillus: unveiling biotechnological prospects-sources, properties, and diverse applications.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Review
  16. Article
  17. Review
  18. Suppression of Fusarium Wilt in Watermelon byJournal of fungi (Basel, Switzerland) · 2023
    Article
  19. Construction ofFrontiers in microbiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yulei DangKey Laboratory of Molecular Microbiology and Technology for Ministry of Education, Nankai University, Tianjin, 300071, China.
Fengjie ZhaoKey Laboratory of Molecular Microbiology and Technology for Ministry of Education, Nankai University, Tianjin, 300071, China.
Xiangsheng LiuKey Laboratory of Molecular Microbiology and Technology for Ministry of Education, Nankai University, Tianjin, 300071, China.
Xu FanKey Laboratory of Molecular Microbiology and Technology for Ministry of Education, Nankai University, Tianjin, 300071, China.
Rui HuangKey Laboratory of Molecular Microbiology and Technology for Ministry of Education, Nankai University, Tianjin, 300071, China.
Weixia GaoState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, 300071, China. watersave@126.com.
Shufang WangState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, 300071, China. wangshufang@nankai.edu.cn.
Chao YangKey Laboratory of Molecular Microbiology and Technology for Ministry of Education, Nankai University, Tianjin, 300071, China. yangc20119@nankai.edu.cn.
Nankai University · CN

Funding

the National Natural Science Funding of China 31570035the National Natural Science Funding of China 31670093the Postdoctoral Science Funding of China 2018M631729the Tianjin Natural Science Funding 17JCZDJC32100the Tianjin Natural Science Funding 18JCYBJC24500
6 · The paper itself

Abstract

backgroundIturins, which belong to antibiotic cyclic lipopeptides mainly produced by Bacillus sp., have the potential for application in biomedicine and biocontrol because of their hemolytic and antifungal properties. Bacillus amyloliquefaciens LL3, isolated previously by our lab, possesses a complete iturin A biosynthetic pathway as shown by genomic analysis. Nevertheless, iturin A could not be synthesized by strain LL3, possibly resulting from low transcription level of the itu operon.

resultsIn this work, enhanced transcription of the iturin A biosynthetic genes was implemented by inserting a strong constitutive promoter C2up into upstream of the itu operon, leading to the production of iturin A with a titer of 37.35 mg l

conclusionsTo our knowledge, this is the first report on simultaneous production of four iturin A homologs (C

Indexed as

Metabolic EngineeringAntifungal AgentsBacillus amyloliquefaciensBiosynthetic PathwaysFermentationGenome, BacterialLipopeptidesOperonPeptides, CyclicPromoter Regions, GeneticTranscription, GeneticAntifungal Agentsiturin ALipopeptidesPeptides, CyclicBacillus amyloliquefaciensIturin APleiotropic regulatorPromoter substitutionResponse surface methodology

Identifiers

PMID30971238
PMCPMC6457013
OpenAlexW2944793593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.